Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The 2nd PP

<< Previous

Bullboard Posts

Next >>

Comment by NgamiaSwedeon Oct 05, 2022 7:26am

209 Views

Post# 35006045

RE:The 2nd PP

My guess
Me and some others did get the Q about the first PP, but not many at all. When the news came investors started to call and see if there was still time to jump on

I think they opened upp again, why turn down investors. We have no clue about the future, covid, war or some new idiot. More money is only better, investors fell safer if the box is full

glta

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments